GDR Insider Trading (genedrive)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £15,652.26
genedrive Share Price & Price History
Current Price: GBX 19.20
Price Change: ▲ Price Increase of +1.2 (6.67%)
As of 07/4/2022 05:12 PM ET
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily | Ad
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
genedrive Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/23/2022 | Matthew Fowler | Insider | Sell | 86,957 | GBX 18 | £15,652.26 | | |
| 2/4/2020 | David Budd | Insider | Buy | 43,330 | GBX 12 | £5,199.60 | | |
| 11/22/2019 | Ian David Gilham | Insider | Buy | 48,000 | GBX 21 | £10,080 | | |
| 7/17/2019 | Ian David Gilham | Insider | Buy | 51,250 | GBX 19 | £9,737.50 | | |
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily | Ad
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
SEC Filings (Institutional Ownership Changes) for genedrive (LON:GDR)
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.
Read More on genedrive
Today's Range
Now: GBX 19.20
50 Day Range
MA: GBX 22.89
52 Week Range
Now: GBX 19.20
Volume
527,185 shs
Average Volume
2,935,157 shs
Market Capitalization
£17.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of genedrive?
